Thursday's ruling comes as a relief to reproductive rights advocates and a disappointment to the pro-life community.On Thursday, the U.S Supreme Court rejected a challenge to restricting access to the abortion drug, Mifepristone, effectively shutting down a plea by a group of physicians with anti-abortion views to block circulation of the widely-used pill.
However, the case will be sent back to the district court, and litigation is likely to continue. U.S. District Judge Matthew J. Kacsmaryk initially ruled to revoke the FDA’s approval of Mifepristone and place additional restrictions on the pill. According to Kumar, the group of physicians were able to “cherry-pick” their way through the lower courts to get the matter before the country’s highest court, “We shouldn’t even be here right now,” he said.
Despite not being surprised by it, O’Donnell noted that it was disappointing and put the health, lives and future fertility of women and girls in the country at risk. Medical professionals often reject this claim and cite the FDA’s 24-year-old approval of Mifepristone.
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: CNN - 🏆 4. / 95 اقرأ أكثر »